5 Am Venture Management, LLC Portfolio Holdings

5 Am Venture Management, LLC

  • $149 Million
  • Q2 2025

5 Am Venture Management, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $149 Million distributed in 29 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Entrada Therapeutics, Inc. with a value of $29M, Pharvaris N.V. with a value of $14M, Moon Lake Immunotherapeutics with a value of $13.3M, Centessa Pharmaceuticals PLC with a value of $10.9M, and Viridian Therapeutics, Inc.\De with a value of $10.3M.

Examining the 13F form we can see an increase of $4.72M in the current position value, from $144M to 149M.

5 Am Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about 5 Am Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $149 Million
Healthcare: $149 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$162M
$29 Million 19.43% of portfolio
4,308,379
Q2 2025 Reduced 2.27%
$712M
$14 Million 9.42% of portfolio
797,600
Q4 2023 Added 35.74%
$2.04B
$13.3 Million 8.94% of portfolio
282,313
Q1 2024 Reduced 6.71%
$1.61B
$10.9 Million 7.33% of portfolio
830,945
Q4 2024 Reduced 35.34%
$717M
$10.3 Million 6.91% of portfolio
736,595
Q1 2024 Added 25.57%
$63.2M
$10.3 Million 6.91% of portfolio
6,361,723
Q4 2021 Reduced 4.94%
$1.11B
$10.1 Million 6.79% of portfolio
497,270
Q4 2023 Added 60.27%
$366M
$9.88 Million 6.63% of portfolio
1,050,000
Q3 2024 Added 2,000.0%
$445M
$8.99 Million 6.03% of portfolio
939,298
Q1 2024 Added 69.25%
$632M
$6.98 Million 4.68% of portfolio
572,665
Q1 2024 Added 41.61%
$191M
$6.86 Million 4.61% of portfolio
5,405,404
Q2 2024 New
$3.06B
$5.02 Million 3.37% of portfolio
189,593
Q4 2024 Reduced 20.19%
$132M
$4.57 Million 3.07% of portfolio
1,200,647
Q1 2023 Reduced 56.1%
$201M
$2.76 Million 1.85% of portfolio
476,200
Q1 2024 New
$34.6M
$2.42 Million 1.63% of portfolio
800,000
Q4 2024 New
$165M
$1.39 Million 0.94% of portfolio
995,841
Q4 2024 New
$80.3M
$568,000 0.38% of portfolio
490,000
Q2 2023 New
$590M
$391,000 0.26% of portfolio
1,305,000
Q2 2023 Added 10.13%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 50.0%
Artiva Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Biohaven LTD
-
$0 0.0% of portfolio
-
Q3 2024 Added 1.92%
Camp4 Therapeutics Corp
-
$0 0.0% of portfolio
-
Q4 2024 New
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 4.18%
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 14.25%
Surrozen Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Skye Bioscience Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 2.62%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 41.59%
Adverum Biotechnologies Inc
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 29
  • Current Value $149 Million
  • Prior Value $144 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track 5 Am Venture Management, LLC Portfolio

Follow 5 Am Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 5 Am Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email